Optimizing the Efficacy of mRNA-based Cancer Vaccines to Generate Potent and Long-lasting CD8+ Responses

Time: 3:30 pm
day: Day One


  • Learning from preclinical models to guide and optimize mRNA-based
    vaccine platforms
  • Deciding the best combination therapy to use with mRNA
  • Determining anti-tumor T cell efficacy and future directions